1. Home
  2. PAHC vs AVDL Comparison

PAHC vs AVDL Comparison

Compare PAHC & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • AVDL
  • Stock Information
  • Founded
  • PAHC 1946
  • AVDL 2015
  • Country
  • PAHC United States
  • AVDL Ireland
  • Employees
  • PAHC N/A
  • AVDL N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAHC Health Care
  • AVDL Health Care
  • Exchange
  • PAHC Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • PAHC 968.3M
  • AVDL 861.4M
  • IPO Year
  • PAHC 2014
  • AVDL 1996
  • Fundamental
  • Price
  • PAHC $29.49
  • AVDL $10.83
  • Analyst Decision
  • PAHC Hold
  • AVDL Strong Buy
  • Analyst Count
  • PAHC 4
  • AVDL 7
  • Target Price
  • PAHC $24.50
  • AVDL $18.71
  • AVG Volume (30 Days)
  • PAHC 341.9K
  • AVDL 1.6M
  • Earning Date
  • PAHC 08-27-2025
  • AVDL 08-07-2025
  • Dividend Yield
  • PAHC 1.63%
  • AVDL N/A
  • EPS Growth
  • PAHC 140.17
  • AVDL N/A
  • EPS
  • PAHC 0.78
  • AVDL N/A
  • Revenue
  • PAHC $1,190,682,000.00
  • AVDL $194,450,000.00
  • Revenue This Year
  • PAHC $28.13
  • AVDL $56.86
  • Revenue Next Year
  • PAHC $13.11
  • AVDL $30.45
  • P/E Ratio
  • PAHC $37.79
  • AVDL N/A
  • Revenue Growth
  • PAHC 19.12
  • AVDL 252.64
  • 52 Week Low
  • PAHC $16.16
  • AVDL $6.38
  • 52 Week High
  • PAHC $31.80
  • AVDL $17.30
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 64.77
  • AVDL 72.02
  • Support Level
  • PAHC $29.64
  • AVDL $8.74
  • Resistance Level
  • PAHC $31.71
  • AVDL $9.56
  • Average True Range (ATR)
  • PAHC 1.07
  • AVDL 0.41
  • MACD
  • PAHC -0.01
  • AVDL 0.18
  • Stochastic Oscillator
  • PAHC 69.12
  • AVDL 89.88

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: